Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Bhutan.
Press releases published on October 23, 2025
Nicox Provides First Half 2025 Financial Results
New Drug Application (NDA) submissions for NCX 470 expected in 2026 in the U.S. and China Company believes that it can finance its existing operations for at least 12 months and expects to fully repay existing financial debts in 2026 October 23, 2025 – …
Nicox : Résultats financiers du premier semestre 2025
23 octobre 2025 – publication à 7H30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une société internationale spécialisée en ophtalmologie, annonce aujourd’hui les résultats financiers de Nicox SA (la « …
Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and Sanofi today announced an expansion of their partnership to bolster clinical research. This …
Cannabix Technologies announces Stock Option Grant
VANCOUVER, British Columbia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports it has granted 2,500,000 incentive stock options (“the Options”) to certain …
BrightCraft Dental Announces Comprehensive Sedation and Digital Full-Arch Transformation Model in Burbank
BURBANK, CA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- BrightCraft Dental announced the launch of its new transformative care model centered on sedation (“sleep dentistry”), digital implant planning, and full-arch restorative solutions at its Burbank practice. …
HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
— First investigational drug candidate using the HUTCHMED ATTC technology platform to create potent targeted therapy payloads while mitigating related toxicities — — Unique, highly potent PI3K/PIKK inhibitor payload optimized to exploit antibody-conjugate …